Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Pain Stages of Change Questionnaire (PSOCQ)

Aug 14, 2017/Test & Measure

This tool is used to assess adults and adolescents who have chronic pain.

CMS Sheds More Light on the PTA Modifier; APTA Updates Its Quick Guide

Mar 8, 2021/News

Expanded CMS resources include more examples. APTA revised its guide and offers additional insight.

Legendary Physical Therapist Advocate Clem Eischen Dies

Jan 12, 2021/News

Eischen's drive and creativity were instrumental in the passage of historic legislation to include outpatient PTs under Medicare Part B.

House Members Push for Better PTA, OTA Supervision Rules Under Medicare

May 10, 2022/News

Representatives are urging an APTA-backed move to general supervision for PTAs in outpatient settings.

Is AI Making Claim Denials in Error? What Does It Matter if We Don't Appeal?

Dec 13, 2023/Perspective

The rise of AI in the commercial payer world means we need to be more vigilant in appealing denials.

Hip Outcome Score (HOS)

Oct 9, 2024/Test & Measure

The Hip Outcome Score (HOS) assesses self-reported functional status of those with musculoskeletal hip disorders.

MIPS Value Pathways

Feb 27, 2024/Resource

MIPS Value Pathways, or MVPs, are a voluntary reporting option that clinicians can participate in as an alternative to traditional MIPS or an APM Performance Pathway.

Coronavirus Update: Jan. 25

Jan 25, 2022/Roundup

Updated APTA practice advisory, a possible decrease in cases (with caveats), PTSD in health care workers, and more.

Final 2024 Home Health Rule: Offsets Blunt Cuts; Lymphedema Benefit Now in Place

Nov 7, 2023/Review

Market basket adjustments set the stage for a slight increase in 2024, and Medicare will cover compression treatment items.

Takeaways From the Proposed 2025 Medicare Physician Fee Schedule, Part 1

Jul 16, 2024/News

Cuts continue, but APTA's advocacy helped spark positive movement related to PTA supervision, prior authorization, and more.